Abstract
A stability-indicating reversed-phase liquid chromatography (RP-LC) method was validated for the assessment of recombinant human interleukin-11 (rhIL-11), based on the ICH guidelines. The method was carried out on a Jupiter C4 column (250 mm × 4.6 mm i.d.), maintained at 25°C. The mobile phase A consisted of 0.1% trifluoroacetic acid (TFA) and the mobile phase B was acetonitrile with 0.1% TFA, run at a flow rate of 1 mL/min, and using a photodiode array (PDA) detection at 214 nm. Separation was obtained with a retention time of 27.6 min, and was linear over the concentration range of 1 – 200 µg/mL (r2 = 0.9995). Specificity was established in degradation studies, which also showed that there was no interference of the excipients. The accuracy was 100.22% with bias lower than 1.25%. Moreover, the in vitro cytotoxicity test of the degraded products showed non-significant differences (p > 0.05). The method was applied to the assessment of rhIL-11 and related proteins in biopharmaceutical dosage forms, and the results were correlated to those of a bioassay.
Similar content being viewed by others
References
M. Ellis, U. Hedstrom, C. Frampton, H. Alizadeh, J. Kristensen, F. V. Shammas, and B. K. al-Ramadi, Clin. Immunol., 2006, 120, 129.
K. Usuki, A. Urabe, Y. Ikeda, Y. Ohashi, H. Mizoguchi, and F. Takaku, Int. J. Hematol., 2007, 85, 159.
S. Yanaka, E. Sano, N. Naruse, K. Miura, M. Futatsumori-Sugai, J. M. M. Caaveiro, and K. Tsumoto, J. Biol. Chem., 2010, 285, 532.
M. Czupryn, F. Bennett, J. Dube, K. Grant, H. Scoble, and J. M. McCoy, Ann. N. Y. Acad. Sci., 1995, 762, 152.
H. Yokota, M. Kishimoto, H. Saito, T. Sakao, S. Yokota, and S. Kojima, J. AOAC Int., 2000A, 83, 1053.
W. Zhang, M. J. Czupry, P. T. Boyle, and J. Amari, Pharm. Res., 2002, 19, 1223.
T. Yin, T. Taga, M. L. Tsang, K. Yasukawa, T. Kishimoto, and Y. Yang, J. Immunol., 1993, 151, 2555.
H. Tan, G. Dan, H. Gong, and L. Cao, Biotechnol. Lett., 2005, 27, 905.
M. Saitoh, K. Taguchi, K. Momose, K. Suga, Y. Ogawa, S. Yasuda, and K. Miyata, Cytokine, 2001, 13, 287.
W. Wang, Int. J. Pharm., 1999, 185, 129.
P. Lara-Quintanar, I. Lacunza, J. Sanz, J. C. Diez-Masa, and M. de Frutos, J. Chromatogr., A, 2007, 1153, 227.
R. A. Kenley and W. W. Nicolas, Pharm. Res., 1994, 11, 72.
J. V. Amari and I. Mazsaroff, J. Chromatogr., A, 1996, 728, 113.
H. Yokota, H. Saito, K. Masuoka, H. Kaniwa, and T. Shibanuma, J. Pharm. Biomed. Anal., 2000B, 24, 317.
W. Garzon-Rodriguez, R. L. Koval, S. Chongprasert, S. Krishnan, T. W. Randolph, N. W. Warne, and J. F. Carpenter, J. Pharm. Sci., 2004, 93, 684.
H. Lee, J. Liq. Chromatogr. Relat. Technol., 2005, 28, 1161.
A. F. Bristow and S. L. Jeffcoate, Biologicals, 1992, 20, 221.
S. L. Dalmora, F. B. D’Avila, L. M. da Silva, A. C. Bergamo, and E. S. Zimmermann, J. Chromatogr., B, 2009, 877, 2471.
B. E. Almeida, J. E. Oliveira, R. Damiani, S. L. Dalmora, P. Bartolini, and M. T. C. P. Ribela, J. Pharm. Biomed. Anal., 2011, 54, 681.
British Pharmacopoeia, The Stationery Office, 2010, London.
ICH, “Guideline on Validation of Analytical Procedure: Text and Methodology Q2(R1)”, in Proceedings of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2005, http://www.ich.org.
ICH, “Guideline on Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products Q6B”, in Proceedings of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1999, http://www.ich.org.
D. R. Nogueira, M. S. Sangoi, L. M. Silva, V. Todeschini, and S. L. Dalmora, J. Sep. Sci., 2008, 31, 3098.
G. A. Shabir, W. L. Lough, S. A. Arain, and T. K. Bradshaw, J. Liq. Chromatogr. Relat. Technol., 2007, 30, 311.
A. Takagi, N. Yamashita, T. Yoshioka, Y. Takaishi, K. Nakanishi, S. Takemura, A. Maeda, K. Saito, Y. Takamura, and M. Hashida, J. Controlled Release, 2006, 115, 134.
G. B. Kresse, Eur. J. Pharm. Biopharm., 2009, 72, 479.
A. Takagi, N. Yamashita, T. Yoshioka, Y. Takaishi, K. Sano, H. Yamaguchi, A. Maeda, K. Saito, Y. Takakura, and M. Hashida, J. Controlled Release, 2007, 119, 271.
A. S. Groot and D. W. Scott, Trends Immunol., 2007, 28, 482.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Souto, R.B., Stamm, F.P., de Ribela, M.T.C.P. et al. Validation of a Stability-indicating RP-LC Method for the Assessment of Recombinant Human Interleukin-11 and Its Correlation with Bioassay. ANAL. SCI. 28, 215–220 (2012). https://doi.org/10.2116/analsci.28.215
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2116/analsci.28.215